Roles of Cofactors in Drug-Induced Liver Injury: Drug Metabolism and Beyond

被引:5
|
作者
Gu, Ruizhi [1 ]
Liang, Alina [2 ]
Liao, Grace [2 ]
To, Isabelle [2 ]
Shehu, Amina [1 ]
Ma, Xiaochao [1 ]
机构
[1] Univ Pittsburgh, Dept Pharmaceut Sci, Ctr Pharmacogenet, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA
基金
美国国家卫生研究院;
关键词
GLUTATHIONE-S-TRANSFERASE; ENDOTHELIAL GROWTH-FACTOR; PREGNANE X RECEPTOR; INDUCED HEPATOTOXICITY; ACETAMINOPHEN HEPATOTOXICITY; OXIDATIVE STRESS; GUT MICROBIOTA; RISK-FACTOR; MODULATES HEPATOTOXICITY; HEPATOCYTE REGENERATION;
D O I
10.1124/dmd.121.000457
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug-induced liver injury (DILI) remains one of the major concerns for healthcare providers and patients. Unfortunately, it is difficult to predict and prevent DILI in the clinic because detailed mechanisms of DILI are largely unknown. Many risk factors have been identified for both ???intrinsic??? and ???idiosyncratic??? DILI, suggesting that cofactors are an important aspect in understanding DILI. This review outlines the cofactors that potentiate DILI and categorizes them into two types: (1) the specific cofactors that target metabolic enzymes, transporters, antioxidation defense, immune response, and liver regeneration; and (2) the general cofactors that include inflammation, age, gender, comorbidity, gut microbiota, and lifestyle. The underlying mechanisms by which cofactors potentiate DILI are also discussed. SIGNIFICANCE STATEMENT This review summarizes the risk factors for DILI, which can be used to predict and prevent DILI in the clinic. This work also highlights the gaps in the DILI field and provides future perspectives on the roles of cofactors in DILI.
引用
收藏
页码:646 / 654
页数:9
相关论文
共 50 条
  • [21] The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury
    Amacher, David E.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (03) : 335 - 347
  • [22] Pregnane X receptor and drug-induced liver injury
    Wang, Yue-Ming
    Chai, Sergio C.
    Brewer, Christopher T.
    Chen, Taosheng
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (11) : 1521 - 1532
  • [23] Genetic Association Studies in Drug-Induced Liver Injury
    Daly, Ann K.
    Day, Chris P.
    SEMINARS IN LIVER DISEASE, 2009, 29 (04) : 400 - 411
  • [24] Incidence and risk factors of drug-induced liver injury
    Li, Xiaoyun
    Tang, Jieting
    Mao, Yimin
    LIVER INTERNATIONAL, 2022, 42 (09) : 1999 - 2014
  • [25] Research Progress of Pharmacogenomics in Drug-Induced Liver Injury
    Shao, Qihui
    Mao, Xinyu
    Zhou, Zhixuan
    Huai, Cong
    Li, Zhiling
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [26] Drug-Induced Liver Injury After Liver Transplantation
    Jimenez-Perez, Miguel
    Gonzalez-Grande, Rocio
    Garcia-Cortes, Miren
    Andrade, Raul J.
    LIVER TRANSPLANTATION, 2020, 26 (09) : 1167 - 1176
  • [27] Drug-Induced Liver Injury - Types and Phenotypes
    Rathi, Sahaj
    Kumar, Pramod
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (14) : 1395 - 1395
  • [28] Mitochondrial Dynamics in Drug-Induced Liver Injury
    Ramachandran, Anup
    Umbaugh, David S.
    Jaeschke, Hartmut
    LIVERS, 2021, 1 (03): : 102 - 115
  • [29] Genetic Predisposition to Drug-Induced Liver Injury
    Stephens, Camilla
    Andrade, Raul J.
    CLINICS IN LIVER DISEASE, 2020, 24 (01) : 11 - +
  • [30] Drug-induced liver injury: a safety review
    Garcia-Cortes, Miren
    Ortega-Alonso, Aida
    Lucena, M. Isabel
    Andrade, Raul J.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (08) : 795 - 804